{"id":"https://openalex.org/W2586476291","doi":"https://doi.org/10.1182/blood.v116.21.4630.4630","title":"Correlative Analysis of T Cell Subpopulations and CD20 Expression In a Phase II Study of Lenalidomide In Combination with Rituximab In Patients with Relapsed or Refractory CLL/SLL","display_name":"Correlative Analysis of T Cell Subpopulations and CD20 Expression In a Phase II Study of Lenalidomide In Combination with Rituximab In Patients with Relapsed or Refractory CLL/SLL","publication_year":2010,"publication_date":"2010-11-19","ids":{"openalex":"https://openalex.org/W2586476291","doi":"https://doi.org/10.1182/blood.v116.21.4630.4630","mag":"2586476291"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v116.21.4630.4630","doi":"https://doi.org/10.1182/blood.v116.21.4630.4630","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v116.21.4630.4630","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061351074","display_name":"Marays Veliz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marays Veliz","raw_affiliation_strings":["Moffitt Cancer Center & Research Institute, H. Lee Moffitt Cancer Center, Tampa, FL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center & Research Institute, H. Lee Moffitt Cancer Center, Tampa, FL, USA,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035905546","display_name":"John Joseph Powers","orcid":"https://orcid.org/0000-0003-3800-2645","observed_orcids":["https://orcid.org/0000-0003-3800-2645"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"John Powers","raw_affiliation_strings":["Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112805891","display_name":"Ling Zhang","orcid":"https://orcid.org/0000-0003-0076-2470","observed_orcids":["https://orcid.org/0000-0003-0076-2470"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ling Zhang","raw_affiliation_strings":["Department of Hematopathology and Clinical Medicine, H. Lee Moffitt Cancer Center, Tampa, FL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematopathology and Clinical Medicine, H. Lee Moffitt Cancer Center, Tampa, FL, USA,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Enrique Santana","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Enrique Santana","raw_affiliation_strings":["Malignant Hematology, H. Lee Moffit Cancer Center, Tampa, FL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Malignant Hematology, H. Lee Moffit Cancer Center, Tampa, FL, USA,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041443589","display_name":"Jeffrey E. Lancet","orcid":"https://orcid.org/0000-0002-7751-7310","observed_orcids":["https://orcid.org/0000-0002-7751-7310"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey E. Lancet","raw_affiliation_strings":["Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010075752","display_name":"Rami S. Komrokji","orcid":"https://orcid.org/0000-0002-1876-5269","observed_orcids":["https://orcid.org/0000-0002-1876-5269"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rami S. Komrokji","raw_affiliation_strings":["Moffitt Cancer Center, Tampa, FL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa, FL, USA,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017327825","display_name":"Mohamed A. Kharfan\u2010Dabaja","orcid":"https://orcid.org/0000-0001-7394-5185","observed_orcids":["https://orcid.org/0000-0001-7394-5185"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mohamed Kharfan-Dabaja","raw_affiliation_strings":["Moffitt Cancer Center, Tampa, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa, USA,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076396878","display_name":"Sara Tinsley","orcid":"https://orcid.org/0000-0003-3012-7398","observed_orcids":["https://orcid.org/0000-0003-3012-7398"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sara Tinsley","raw_affiliation_strings":["Malignant Hematology, H. Lee Moffit Cancer Center and Research Institute, Tampa, FL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Malignant Hematology, H. Lee Moffit Cancer Center and Research Institute, Tampa, FL, USA,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088168204","display_name":"Darcie Deaver","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Darcie Deaver","raw_affiliation_strings":["Malignant Hematology, H. Lee Moffit Cancer Center and Research Institute, Tampa, FL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Malignant Hematology, H. Lee Moffit Cancer Center and Research Institute, Tampa, FL, USA,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108222207","display_name":"Eduardo M. Sotomayor","orcid":"https://orcid.org/0009-0009-5081-3855","observed_orcids":["https://orcid.org/0009-0009-5081-3855"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eduardo M. Sotomayor","raw_affiliation_strings":["Malignant Hematology, H. Lee Moffitt Cancer Ctr. & Rsch. Inst., Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Malignant Hematology, H. Lee Moffitt Cancer Ctr. & Rsch. Inst., Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101811382","display_name":"Javier A. Pinilla-Ibarz","orcid":"https://orcid.org/0000-0003-3170-9648","observed_orcids":["https://orcid.org/0000-0003-3170-9648"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Javier Pinilla-Ibarz","raw_affiliation_strings":["Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA,","institution_ids":["https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5017327825","https://openalex.org/A5035905546","https://openalex.org/A5088168204","https://openalex.org/A5101811382"],"corresponding_institution_ids":["https://openalex.org/I3019308854"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.32764766,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"116","issue":"21","first_page":"4630","last_page":"4630"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.9350000023841858},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9909999966621399},{"id":"https://openalex.org/keywords/relapsed-or-refractory-cll","display_name":"relapsed or refractory CLL","score":0.8159999847412109},{"id":"https://openalex.org/keywords/small-lymphocytic-lymphoma","display_name":"small lymphocytic lymphoma","score":0.9309999942779541},{"id":"https://openalex.org/keywords/t-cell-subsets","display_name":"T cell subsets","score":0.8550000190734863},{"id":"https://openalex.org/keywords/cd20-expression","display_name":"CD20 expression","score":0.9670000076293945},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.8159999847412109},{"id":"https://openalex.org/keywords/th17-cells","display_name":"Th17 cells","score":0.9649999737739563},{"id":"https://openalex.org/keywords/th17-treg-ratio","display_name":"Th17/Treg ratio","score":0.6320000290870667},{"id":"https://openalex.org/keywords/foxp3","display_name":"Foxp3","score":0.5759999752044678},{"id":"https://openalex.org/keywords/il-17a","display_name":"IL-17A","score":0.7149999737739563},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.5109999775886536},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.5559999942779541},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.4009999930858612},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.3190000057220459}],"concepts":[{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.8791674375534058},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7718567848205566},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7498493194580078},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.7236549854278564},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.57822185754776},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5757736563682556},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.5181542634963989},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.5054633617401123},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4844481945037842},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4841088056564331},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.4759809076786041},{"id":"https://openalex.org/C2780775027","wikidata":"https://www.wikidata.org/wiki/Q17141389","display_name":"Salvage therapy","level":3,"score":0.4595659077167511},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4299297332763672},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.41339921951293945},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.41101667284965515},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.36757153272628784},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2787429690361023},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.2531912326812744},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.2337946593761444},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.21045300364494324},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.06648862361907959},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v116.21.4630.4630","doi":"https://doi.org/10.1182/blood.v116.21.4630.4630","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v116.21.4630.4630","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.7900000214576721}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2590111115","https://openalex.org/W2594796980","https://openalex.org/W2536534414","https://openalex.org/W2568433166","https://openalex.org/W2502524943","https://openalex.org/W2573030598","https://openalex.org/W2547905732","https://openalex.org/W2559725481","https://openalex.org/W2302686310","https://openalex.org/W2558585013"],"abstract_inverted_index":{"Abstract":[0,1],"4630":[2],"Background:":[3],"The":[4,531,560,600,621,639],"prognosis":[5],"of":[6,27,40,54,70,127,163,183,269,286,289,292,300,316,322,325,336,350,379,383,403,413,415,450,516,539,544,562,579,602,632,641,658],"patient":[7],"with":[8,15,33,46,94,229,331,342,409,429,440,446,452,519,552,571,604,609,616,625,629,651],"relapsed":[9,47,95,617],"or":[10,48,96,172,618],"refractory":[11,25,49,97,619],"CLL/SLL":[12,98,343],"is":[13,295,606],"dismal":[14],"an":[16,52,332],"overall":[17],"response":[18,201,414],"rate":[19,438],"(ORR)":[20],"to":[21,198,283,305,309,550],"salvage":[22],"therapy":[23,390,442,518,554],"for":[24,132,156,200,212,266,418,427],"patients":[26,45,341,385,404,419,428,615,649],"10\u201330%,":[28],"and":[29,74,81,86,117,135,179,181,189,206,231,261,277,391,424,498,508,555],"limited":[30],"survival":[31],"benefit":[32,398],"current":[34],"treatment":[35,228,451,524],"approaches.":[36],"Phase":[37],"II":[38],"studies":[39,61,214,502],"single":[41],"agent":[42],"lenalidomide":[43,65,101,216,517,540,553,603,642],"in":[44,59,129,313,377,401,612,636,648],"CLL":[50],"revealed":[51],"ORR":[53,177],"32\u201358%":[55],"(7-17%":[56],"CR).":[57],"Recent":[58],"vitro":[60],"have":[62],"shown":[63],"that":[64,504],"enhances":[66],"the":[67,83,184,244,267,290,310,314,380,384,436,526,542,577,586,597,630,644,659],"rituximab-induced":[68],"killing":[69],"NHL":[71],"cell":[72,90,318,646],"lines":[73],"B-CLL":[75],"cells":[76,327,547,588],"by":[77,124,585],"enhancing":[78],"ADCC":[79],"activity":[80,611],"restoring":[82],"defective":[84],"T-cell":[85,270],"NK-cell":[87],"mediated":[88],"tumor":[89,463],"cytotoxicity.":[91],"Methods:":[92],"Patients":[93],"received":[99,387],"oral":[100],"via":[102],"dose":[103],"escalation":[104],"as":[105,297,303,569],"follows:":[106],"2.5":[107],"mg":[108,113,119,138],"on":[109,114,120,141,144,160,346,525,643],"days":[110,115,121,126,142,224],"1\u20137,":[111],"5":[112],"8\u201314":[116],"10":[118],"15\u201321":[122],"followed":[123],"7":[125],"rest":[128],"28-day":[130,146],"cycle;":[131],"cycle":[133,164],"2":[134,196],"beyond":[136],"20":[137],"was":[139,149,167,217,221,241,281,353,359,399,534,583],"given":[140],"1\u201321":[143],"a":[145,284,410,422,447,607],"cycle.":[147],"Rituximab":[148],"dosed":[150],"at":[151,596,662],"375":[152],"mg/m2":[153],"IV":[154],"weekly":[155],"4":[157],"weeks":[158],"starting":[159],"day":[161],"15":[162],"1.":[165],"Treatment":[166],"continued":[168,441],"until":[169,236],"disease":[170,237,480],"progression":[171],"toxicity.":[173],"Primary":[174],"objectives":[175],"were":[176,193,210,264,329,344,375,393,434,458],"(CR+PR)":[178],"safety":[180],"tolerability":[182],"combination":[185,601,622],"regimen.":[186],"CT":[187],"scans,":[188],"bone":[190,207,565],"marrow":[191,208,566],"biopsies":[192],"done":[194],"every":[195,233],"months":[197,235,417,426],"assess":[199],"(NCI-WG":[202],"2008).":[203],"Peripheral":[204],"blood":[205,506],"aspirates":[209],"collected":[211,282],"correlative":[213],"before":[215,219],"initiated,":[218],"rituximab":[220,230,488,523,572,580,605,652],"initiated":[222],"(between":[223],"13\u201315),":[225],"after":[226,320,514,522,537,558,576],"finishing":[227],"then":[232],"two":[234,634],"progression.":[238],"Flow":[239],"cytometry":[240],"performed":[242],"using":[243],"following":[245],"antibodies":[246],"CD3,":[247],"CD4,":[248],"CD5,":[249],"CD8,":[250],"CD19,":[251],"CD20,":[252],"CD23,":[253],"CD40,":[254],"CD45RA,":[255],"CD62L,":[256],"CD80,":[257],"CD86,":[258],"CD95,":[259],"IL-17A":[260],"FoxP3.":[262],"Panels":[263],"created":[265],"analysis":[268,657],"memory/nai\u0308ve":[271,328],"populations,":[272,274],"B-cell":[273],"regulatory":[275,545],"T-cells":[276],"Th17":[278,532],"cells.":[279],"Data":[280,294],"limit":[285],"10,000":[287],"events":[288,627],"population":[291,335],"interest.":[293],"presented":[296,595],"total":[298],"number":[299,315,349],"cells/ul":[301],"instead":[302],"percentage":[304],"avoid":[306],"misinterpretation":[307],"due":[308],"dramatic":[311],"reduction":[312],"B":[317,587],"lymphocytes":[319],"initiation":[321,515,538],"therapy.":[323],"Subpopulation":[324],"T":[326,546,645],"compared":[330],"age":[333,358],"matched":[334],"normal":[337],"controls.":[338],"Results:":[339],"18":[340,416],"enrolled":[345],"study.":[347],"Median":[348,357],"prior":[351,388],"chemotherapies":[352],"3":[354],"(range":[355,362],"1\u20135).":[356],"63":[360],"years":[361],"42\u201380).":[363],"High":[364],"risk":[365],"cytogenetic":[366],"abnormalities":[367],"(del11q":[368],"(11%),":[369,372,487,492,495,497],"del":[370],"17p/p53":[371],"complex":[373],"(22%))":[374],"observed":[376,626],"44%":[378],"patients.":[381],"95%":[382],"had":[386],"fludarabine":[389,394],"50%":[392,407],"refractory.":[395],"Overall":[396],"clinical":[397,610],"seen":[400],"92%":[402],"(42%":[405],"PR,":[406,435],"SD)":[408],"median":[411],"duration":[412,449],"who":[420],"achieved":[421],"PR":[423,437],"12":[425],"SD.":[430],"Although":[431],"all":[432],"responses":[433,445],"improved":[439],"suggesting":[443],"increased":[444],"longer":[448],"lenalidomide.":[453],"Most":[454],"common":[455],"adverse":[456],"effects":[457],"neutropenia":[459],"(50%":[460],"grade":[461,466,469,473,476,482],"3\u20134),":[462,470,477,483],"flare":[464],"(28%":[465],"1\u20132,":[467,474],"11%":[468],"fatigue":[471],"(11%":[472,481],"6%":[475],"venous":[478],"thromboembolic":[479],"acute":[484],"renal":[485],"insufficiency":[486],"related":[489],"infusion":[490],"reactions":[491],"flu-like":[493],"symptoms":[494],"infections":[496],"hypercalcemia":[499],"(11%).":[500],"Correlative":[501],"showed":[503],"peripheral":[505],"CD4":[507,527],"CD8":[509],"effector":[510,528],"memory":[511,529],"subpopulations":[512,647],"decreased":[513,536,568],"subsequent":[520],"elevation":[521],"compartment.":[530,589],"compartment":[533,661],"minimally":[535],"while":[541],"levels":[543],"(Tregs)":[548],"appeared":[549],"decrease":[551],"increase":[556],"slightly":[557],"rituximab.":[559],"expression":[561,582],"CD20":[563,581],"from":[564],"samples":[567],"expected":[570],"therapy;":[573],"however":[574],"shortly":[575],"discontinuation":[578],"regained":[584],"Later":[590],"time":[591,664],"points":[592,665],"will":[593,666],"be":[594,667],"meeting.":[598],"Conclusions":[599],"promising":[608],"heavily":[613],"pretreated":[614],"CLL.":[620],"appears":[623],"tolerable":[624],"consistent":[628],"use":[631],"these":[633],"agents":[635],"other":[637],"studies.":[638],"impact":[640],"treated":[650],"remains":[653],"unclear.":[654],"A":[655],"detailed":[656],"BM":[660],"latter":[663],"investigated.":[668],"Disclosures:":[669],"Lancet:":[670],"Eisai:":[671],"Consultancy;":[672],"Celgene:":[673],"Honoraria.":[674],"Komrokji:Genentech:":[675],"Research":[676],"Funding.":[677]},"counts_by_year":[{"year":2015,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2017-02-17T00:00:00"}